140 related articles for article (PubMed ID: 38518604)
1. Senolytic drugs dasatinib and quercetin combined with Carboplatin or Olaparib reduced the peritoneal and adipose tissue metastasis of ovarian cancer.
Wang L; Xiong B; Lu W; Cheng Y; Zhu J; Ai G; Zhang X; Liu X; Cheng Z
Biomed Pharmacother; 2024 May; 174():116474. PubMed ID: 38518604
[TBL] [Abstract][Full Text] [Related]
2. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
[TBL] [Abstract][Full Text] [Related]
3. Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age.
Islam MT; Tuday E; Allen S; Kim J; Trott DW; Holland WL; Donato AJ; Lesniewski LA
Aging Cell; 2023 Feb; 22(2):e13767. PubMed ID: 36637079
[TBL] [Abstract][Full Text] [Related]
4. Targeting senescent cells alleviates obesity-induced metabolic dysfunction.
Palmer AK; Xu M; Zhu Y; Pirtskhalava T; Weivoda MM; Hachfeld CM; Prata LG; van Dijk TH; Verkade E; Casaclang-Verzosa G; Johnson KO; Cubro H; Doornebal EJ; Ogrodnik M; Jurk D; Jensen MD; Chini EN; Miller JD; Matveyenko A; Stout MB; Schafer MJ; White TA; Hickson LJ; Demaria M; Garovic V; Grande J; Arriaga EA; Kuipers F; von Zglinicki T; LeBrasseur NK; Campisi J; Tchkonia T; Kirkland JL
Aging Cell; 2019 Jun; 18(3):e12950. PubMed ID: 30907060
[TBL] [Abstract][Full Text] [Related]
5. A study of the molecular mechanism of quercetin and dasatinib combination as senolytic in alleviating age-related and kidney diseases.
Alharbi KS; Afzal O; Altamimi ASA; Almalki WH; Kazmi I; Al-Abbasi FA; Alzarea SI; Makeen HA; Albratty M
J Food Biochem; 2022 Dec; 46(12):e14471. PubMed ID: 36268851
[TBL] [Abstract][Full Text] [Related]
6. Senolytic treatment reverses obesity-mediated senescent cell accumulation in the ovary.
Hense JD; Garcia DN; Isola JV; Alvarado-Rincón JA; Zanini BM; Prosczek JB; Stout MB; Mason JB; Walsh PT; Brieño-Enríquez MA; Schadock I; Barros CC; Masternak MM; Schneider A
Geroscience; 2022 Jun; 44(3):1747-1759. PubMed ID: 35460445
[TBL] [Abstract][Full Text] [Related]
7. Sexual dimorphic metabolic and cognitive responses of C57BL/6 mice to Fisetin or Dasatinib and quercetin cocktail oral treatment.
Fang Y; Medina D; Stockwell R; McFadden S; Quinn K; Peck MR; Bartke A; Hascup KN; Hascup ER
Geroscience; 2023 Oct; 45(5):2835-2850. PubMed ID: 37296266
[TBL] [Abstract][Full Text] [Related]
8. Cellular senescence of granulosa cells in the pathogenesis of polycystic ovary syndrome.
Tanaka T; Urata Y; Harada M; Kunitomi C; Kusamoto A; Koike H; Xu Z; Sakaguchi N; Tsuchida C; Komura A; Teshima A; Takahashi N; Wada-Hiraike O; Hirota Y; Osuga Y
Mol Hum Reprod; 2024 Apr; 30(5):. PubMed ID: 38603629
[TBL] [Abstract][Full Text] [Related]
9. BRCA Status Does Not Predict Synergism of a Carboplatin and Olaparib Combination in High-Grade Serous Ovarian Cancer Cell Lines.
Shen YT; Evans JC; Zafarana G; Allen C; Piquette-Miller M
Mol Pharm; 2018 Jul; 15(7):2742-2753. PubMed ID: 29750868
[TBL] [Abstract][Full Text] [Related]
10. Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer.
Gupta VG; Hirst J; Petersen S; Roby KF; Kusch M; Zhou H; Clive ML; Jewell A; Pathak HB; Godwin AK; Wilson AJ; Crispens MA; Cybulla E; Vindigni A; Fuh KC; Khabele D
Gynecol Oncol; 2021 Jul; 162(1):163-172. PubMed ID: 33867143
[TBL] [Abstract][Full Text] [Related]
11. Transient metabolic improvement in obese mice treated with navitoclax or dasatinib/quercetin.
Sierra-Ramirez A; López-Aceituno JL; Costa-Machado LF; Plaza A; Barradas M; Fernandez-Marcos PJ
Aging (Albany NY); 2020 Jun; 12(12):11337-11348. PubMed ID: 32584785
[TBL] [Abstract][Full Text] [Related]
12. Senolytic Combination of Dasatinib and Quercetin Alleviates Intestinal Senescence and Inflammation and Modulates the Gut Microbiome in Aged Mice.
Saccon TD; Nagpal R; Yadav H; Cavalcante MB; Nunes ADC; Schneider A; Gesing A; Hughes B; Yousefzadeh M; Tchkonia T; Kirkland JL; Niedernhofer LJ; Robbins PD; Masternak MM
J Gerontol A Biol Sci Med Sci; 2021 Oct; 76(11):1895-1905. PubMed ID: 33406219
[TBL] [Abstract][Full Text] [Related]
13. Senolytics improve physical function and increase lifespan in old age.
Xu M; Pirtskhalava T; Farr JN; Weigand BM; Palmer AK; Weivoda MM; Inman CL; Ogrodnik MB; Hachfeld CM; Fraser DG; Onken JL; Johnson KO; Verzosa GC; Langhi LGP; Weigl M; Giorgadze N; LeBrasseur NK; Miller JD; Jurk D; Singh RJ; Allison DB; Ejima K; Hubbard GB; Ikeno Y; Cubro H; Garovic VD; Hou X; Weroha SJ; Robbins PD; Niedernhofer LJ; Khosla S; Tchkonia T; Kirkland JL
Nat Med; 2018 Aug; 24(8):1246-1256. PubMed ID: 29988130
[TBL] [Abstract][Full Text] [Related]
14. Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics.
Gao Y; Wu T; Tang X; Wen J; Zhang Y; Zhang J; Wang S
Geroscience; 2023 Jun; 45(3):1775-1790. PubMed ID: 36648735
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib plus quercetin attenuates some frailty characteristics in SAMP10 mice.
Ota H; Kodama A
Sci Rep; 2022 Feb; 12(1):2425. PubMed ID: 35165353
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal delivery of NanoOlaparib for disseminated late-stage cancer treatment.
Baldwin P; Ohman AW; Tangutoori S; Dinulescu DM; Sridhar S
Int J Nanomedicine; 2018; 13():8063-8074. PubMed ID: 30555227
[TBL] [Abstract][Full Text] [Related]
17. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
Murakami T; Inagaki N; Kondoh H
Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
[TBL] [Abstract][Full Text] [Related]
18. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.
Zhu Y; Tchkonia T; Pirtskhalava T; Gower AC; Ding H; Giorgadze N; Palmer AK; Ikeno Y; Hubbard GB; Lenburg M; O'Hara SP; LaRusso NF; Miller JD; Roos CM; Verzosa GC; LeBrasseur NK; Wren JD; Farr JN; Khosla S; Stout MB; McGowan SJ; Fuhrmann-Stroissnigg H; Gurkar AU; Zhao J; Colangelo D; Dorronsoro A; Ling YY; Barghouthy AS; Navarro DC; Sano T; Robbins PD; Niedernhofer LJ; Kirkland JL
Aging Cell; 2015 Aug; 14(4):644-58. PubMed ID: 25754370
[TBL] [Abstract][Full Text] [Related]
19. Chronic hyperinsulinemia promotes human hepatocyte senescence.
Baboota RK; Spinelli R; Erlandsson MC; Brandao BB; Lino M; Yang H; Mardinoglu A; Bokarewa MI; Boucher J; Kahn CR; Smith U
Mol Metab; 2022 Oct; 64():101558. PubMed ID: 35872305
[TBL] [Abstract][Full Text] [Related]
20. Senolytic effects of quercetin in an in vitro model of pre-adipocytes and adipocytes induced senescence.
Zoico E; Nori N; Darra E; Tebon M; Rizzatti V; Policastro G; De Caro A; Rossi AP; Fantin F; Zamboni M
Sci Rep; 2021 Dec; 11(1):23237. PubMed ID: 34853352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
